Defining a Simulation Strategy for Cancer Immunocompetence

  • Grazziela P. Figueredo
  • Uwe Aickelin
Part of the Lecture Notes in Computer Science book series (LNCS, volume 6209)


Although there are various types of cancer treatments, none of these currently take into account the effect of ageing of the immune system and hence altered responses to cancer. Recent studies have shown that in vitro stimulation of T cells can help in the treatment of patients. There are many factors that have to be considered when simulating an organism’s immunocompetence. Our particular interest lies in the study of loss of immunocompetence with age. We are trying to answer questions such as: Given a certain age of a patient, how fit is their immune system to fight cancer? Would an immune boost improve the effectiveness of a cancer treatment given the patient’s immune phenotype and age? We believe that understanding the processes of immune system ageing and degradation through computer simulation may help in answering these questions. Specifically, we have decided to look at the change in numbers of naive T cells with age, as they play a important role in responses to cancer and anti-tumour vaccination. In this work we present an agent-based simulation model to understand the interactions which influence the naive T cell populations over time. Our agent model is based on existing mathematical system dynamic model, but in comparisons offers better scope for customisation and detailed analysis. We believe that the results obtained can in future help with the modelling of T cell populations inside tumours.


Simulation Strategy Agent Base Simulation Naive Cell Thymic Output Tumoural Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Metheringham, R.L., Pudney, V.A., Gunn, B., Towey, M., Spendlove, I., Durrant, L.G.: Antibodies designed as effective cancer vaccines. mAbs 1, 71–85 (2009)CrossRefGoogle Scholar
  2. 2.
    Pudney, V.A., Metheringham, R.L., Gunn, B., Spendlove, I., Ramage, J.M., Durrant, L.G.: DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cells. European Journal of Immunology 40, 899–910 (2009)CrossRefGoogle Scholar
  3. 3.
    Murray, J.M., Kaufmann, G.R., Hodgkin, P.D., Lewin, S.R., Kelleher, A.D., Davenport, M.P., Zaunders, J.: Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after twenty. Immunology and Cell Biology 81, 487–495 (2003)CrossRefGoogle Scholar
  4. 4.
    Bulatti, M., Pellican, M., Vasto, S., Colonna-Romano, G.: Understanding ageing: Biomedical and bioengineering approaches, the immunologic view. Immunity & Ageing 5 (2008)Google Scholar
  5. 5.
    Franceschi, C., Bonaf, M., Valensin, S.: Human immonosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18, 1717–1720 (2000)CrossRefGoogle Scholar
  6. 6.
    Wu, D., Meydani, S.N.: Mechanism of age-associated up-regulation in macrophage PGE2 synthesis. Brain, Behavior, and Immunity 18, 487–494 (2004)CrossRefGoogle Scholar
  7. 7.
    Martinis, M.D., Franceschi, C., Monti, D., Ginaldi, L.: Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS 579, 2035–2039 (2005)CrossRefGoogle Scholar
  8. 8.
    Eric Boren, M.E.G.: Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmunity reviews 3, 401–406 (2004)CrossRefGoogle Scholar
  9. 9.
    Butcher, S., Chahel, H., Lord, J.M.: Ageing and the neutrophil: no appetite for killing? Immunology 100, 411–416 (2000)CrossRefGoogle Scholar
  10. 10.
    Agrawal, A., Agrawal, S., Tay, J., Gupta, S.: Biology of dendritic cells in aging. J. Clin. Immunol. 28, 14–20 (2007)CrossRefGoogle Scholar
  11. 11.
    Sharma, S., Dominguez, A.L., Lustgarten, J.: High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. The Journal of Immunology 177, 8348–8355 (2006)Google Scholar
  12. 12.
    Cossarizza, A., Ortolani, C., Paganelli, R., Barbieri, D., Monti, D., Sansoni, P., Fagiolo, U., Castellani, G., Bersani, F., Londei, M., Franceschi, C.: CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mechanisms of Ageing and Development 86, 173–195 (1996)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Grazziela P. Figueredo
    • 1
  • Uwe Aickelin
    • 1
  1. 1.Intelligent Modelling and Analysis Research Group, School of Computer ScienceThe University of NottinghamUK

Personalised recommendations